Navigation Links
Tasty Baking Company Launches New Krimpet to Support Breast Cancer Awareness Through a Partnership with Breastcancer.Org

Sales of Limited Edition Strawberry Jelly Krimpets Will Benefit Online

Resource for Breast Cancer Support and Information

PHILADELPHIA, Sept. 27 /PRNewswire-FirstCall/ -- Tasty Baking Company today unveiled its most recent philanthropic product offering, the Tastykake Strawberry Jelly Krimpet. 10% of the proceeds from the sale of this limited edition offering will be donated to, a Narberth, Pennsylvania based online resource dedicated to helping women and their loved ones make sense of the complex medical and personal information about breast cancer.

Strawberry Jelly Krimpets, an extension of the legendary sponge cake line, may be purchased in grocery stores and online at, while supplies last, for $3.79 per family pack. Information about will appear on each family pack carton.

"The prevalence of breast cancer in our world is staggering, and offers tremendous knowledge, comfort, and support to people when they need it most," said Autumn R. Bayles, Senior Vice President, Strategic Operations and Technology for Tasty Baking Company. "Utilizing the packaging of the Strawberry Jelly Krimpet to tell the story of helps support the millions of people out there living with the disease and working toward a cure every day."

More than 8 million people visit each year to learn about the disease and its impact on patients and families, while connecting with others going through a similar experience. The site was launched in 1999 by Dr. Marisa Weiss, a breast cancer specialist and author of the acclaimed book, Living Beyond Breast Cancer.

"Despite the widespread consumer awareness of breast cancer as an issue, the disease itself remains quite a confusing and scary experience for the people going through it," according to Dr. Weiss. "The fundraising opportunity that Tastykake has created will have a significant, lasting impact on and the millions of people who visit our site each year." Dr. Weiss is also director of Breast Radiation Oncology at Lankenau Hospital, an acute-care teaching hospital in Wynnewood, PA, where the new product was announced during a news conference.

To learn more about Tasty Baking Company's philanthropic efforts, visit For more information about breast health and breast cancer, visit


Tasty Baking Company (Nasdaq: TSTY), founded in 1914 and headquartered in Philadelphia, Pennsylvania, is one of the country's leading bakers of snack cakes, pies, cookies, and donuts with manufacturing facilities in Philadelphia and Oxford, Pennsylvania. Tasty Baking Company offers more than 100 products under the Tastykake brand name. For more information on Tasty Baking Company, visit In addition, consumers can send Tastykake products throughout the United States from the Company's website or by calling 1-800- 33-TASTY.


Serving 8 million individuals annually, is the premier Internet source for responsible, accurate medical information and visual images about breast cancer, helping patients and survivors manage their breast cancer experience with confidence. The site helps women at every step along the way, including explaining medical terms, detailing treatment options, guiding possible questions for the next doctor's visit, providing suggestions for strengthening critical doctor-patient relationships, and interpreting the latest medical research. For more information, please visit

SOURCE Tasty Baking Company
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Tasty Cosmetic Recipes to flavor your day
2. Birth- Control Made Easy And Tasty
3. Now, Fibre-enriched Tasty Snacks in the Making
4. Baking Soda Treatment for Life-Threatening Asthma
5. Holiday Baking Frenzy May Mask Eating Disorder in College Kids
6. Medicis Pharmaceutical company enters pediatric market
7. Problems Of a Growing Company
8. Teenagers Take More Risk-Taking Behaviors In The Company Of Same Sex Friends
9. British company developing ‘Safer Cigarettes
10. Australian Company Gets $10 million For Developing Skin Cancer Gel
11. Elderly People Prefer The Company Of Pet Dogs
Post Your Comments:
(Date:6/25/2016)... Long Beach, CA (PRWEB) , ... June 25, 2016 , ... ... from UCLA with Magna Cum Laude and his M.D from the David Geffen School ... San Diego and returned to Los Angeles to complete his fellowship in hematology/oncology at ...
(Date:6/25/2016)... ... ... On Friday, June 10, Van Mitchell, Secretary of the Maryland Department of ... recognition of their exemplary accomplishments in worksite health promotion. , The Wellness at Work ... Symposium at the BWI Marriott in Linthicum Heights. iHire was one of 42 businesses ...
(Date:6/24/2016)... ... 2016 , ... A recent article published June 14 on E ... goes on to state that individuals are now more comfortable seeking to undergo not ... as calf and cheek reduction. The Los Angeles area medical group, Beverly Hills Physicians ...
(Date:6/24/2016)... Marne, Michigan (PRWEB) , ... June 24, 2016 , ... ... awareness about the dangers associated with chronic pain and the benefits of holistic treatments, ... for individuals who are suffering with Sickle Cell Disease. , Sickle Cell Disease (SCD) ...
(Date:6/24/2016)... ... 24, 2016 , ... The Pulmonary Hypertension Association (PHA) learned ... receive two significant new grants to support its work to advance research and ... by recognizing patients, medical professionals and scientists for their work in fighting pulmonary ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... 2016  Arkis BioSciences, a leading innovator in ... durable cerebrospinal fluid treatments, today announced it has ... is led by Innova Memphis, followed by Angel ... investors.  Arkis, new financing will accelerate the commercialization ... release of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... , June 23, 2016 Research ... "Pharmaceutical Excipients Market by Type (Organic Chemical (Sugar, Petrochemical, ... (Oral, Topical, Coating, Parenteral) - Global Forecast to 2021" ... The global pharmaceutical excipients market is ... a CAGR of 6.1% in the forecast period 2016 ...
(Date:6/23/2016)... Capricor Therapeutics, Inc. ... company focused on the discovery, development and commercialization ... in its ongoing randomized HOPE-Duchenne clinical trial (Halt ... its 24-patient target. Capricor expects the trial to ... 2016, and to report top line data from ...
Breaking Medicine Technology: